1st longer term tirzepatide study (3 years)
Docs Who Lift - Un pódcast de Docs Who Lift
Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis
